<p>The key pharmacophoric features generated from the binding modes of (A) C1 and (B) Ang I. The amino acid residues of the enzyme are shown in gray thin stick form whereas the bound C1 and Ang I are shown in thick stick form. The secondary structure cartoon of the enzyme is colored based on the hydrophobicity of the amino acid residues. (C) Final hybrid pharmacophore model (D) Hybrid pharmacophore model with distance constraints.</p
A pharmacophore describes the arrangement of molecular features a ligand must contain to efficacious...
This chapter reviews theory related to pharmacophore models and guide the user through six essential...
<p>The model was generated from the 3D structure of PPT and its activities against CYP3A4. PPT fitte...
<p>The pharmacophore model generated from the binding modes of (A) C15 and (B) LTA4. The amino acid ...
A detection of the three-dimensional binding mode between a protein and a chemical compound is valua...
<p>Generated pharmacophore models (A) Hypo A, (B) Hypo B and (C) Hypo C, in which hydrophobic, hydro...
<p>The metal ions and key residues of the representative Shh structure of (a) the Shh-PL2 (slashdot ...
<p>Color coding of pharmacophoric features: green, hydrophobic site; magenta, acceptor site; cyan, d...
Pharmacophore modelling is a well-known structure based drug design method allowing fast virtual scr...
<p>Generated pharmacophore models (A) Hypo A, (B) Hypo B, and (C) Hypo C, consisting of hydrogen-bon...
<p>The interactions are translated into pharmacophore features while the binding site amino acids ar...
Pharmacophore modeling is a successful yet very diverse subfield of computer-aided drug design. The ...
<p>HBA, HBD, and HYP features are displayed in green, magenta, and cyan, respectively.</p
This chapter reviews theory related to pharmacophore models and guide the user through six essential...
This chapter reviews theory related to pharmacophore models and guide the user through six essential...
A pharmacophore describes the arrangement of molecular features a ligand must contain to efficacious...
This chapter reviews theory related to pharmacophore models and guide the user through six essential...
<p>The model was generated from the 3D structure of PPT and its activities against CYP3A4. PPT fitte...
<p>The pharmacophore model generated from the binding modes of (A) C15 and (B) LTA4. The amino acid ...
A detection of the three-dimensional binding mode between a protein and a chemical compound is valua...
<p>Generated pharmacophore models (A) Hypo A, (B) Hypo B and (C) Hypo C, in which hydrophobic, hydro...
<p>The metal ions and key residues of the representative Shh structure of (a) the Shh-PL2 (slashdot ...
<p>Color coding of pharmacophoric features: green, hydrophobic site; magenta, acceptor site; cyan, d...
Pharmacophore modelling is a well-known structure based drug design method allowing fast virtual scr...
<p>Generated pharmacophore models (A) Hypo A, (B) Hypo B, and (C) Hypo C, consisting of hydrogen-bon...
<p>The interactions are translated into pharmacophore features while the binding site amino acids ar...
Pharmacophore modeling is a successful yet very diverse subfield of computer-aided drug design. The ...
<p>HBA, HBD, and HYP features are displayed in green, magenta, and cyan, respectively.</p
This chapter reviews theory related to pharmacophore models and guide the user through six essential...
This chapter reviews theory related to pharmacophore models and guide the user through six essential...
A pharmacophore describes the arrangement of molecular features a ligand must contain to efficacious...
This chapter reviews theory related to pharmacophore models and guide the user through six essential...
<p>The model was generated from the 3D structure of PPT and its activities against CYP3A4. PPT fitte...